Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers

Nutrition Research and Practice

Volumn 5, Issue 1, 2011, Pages 28-33

  Lee, Kyung Hea ^a   Park, Eunju ^b   Lee, Hye Jin ^a   Kim, Myeong Ok ^a   Cha, Yong Jun ^a   Kim, Jung Mi ^b   Lee, Hyeran ^c   Shin, Min Jeong ^c  

^a Changwon National University   (South Korea)

^b Kyungnam University   (South Korea)

^c Korea University   (South Korea)

Author keywords

Cardiometabolic risks; Dyslipidemia; Inflammation; Onion; Quercetin

Indexed keywords

ALLIUM CEPA;

EID: 79955583955     PISSN: 19761457     EISSN: 20056168     Source Type: Journal    
DOI: 10.4162/nrp.2011.5.1.28     Document Type: Article

References (41)

1. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996; 312:478-81.
2. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002;75:880-6.
3. Sesso HD, Gaziano JM, Buring JE, Hennekens CH. Coffee and ea intake and the risk of myocardial infarction. Am J Epidemiol 1999;149:162-7.
4. Arts IC, Hollman PC. Polyphenols and disease risk in idemiologic studies. Am J Clin Nutr 2005;81:317S-325S.
5. Erdman JW Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M, Scalbert A, Vita J, Williamson G, Burrowes J. Flavonoids and heart ealth: proceedings of the ILSI North America Flavonoids orkshop, May 31-June 1, 2005, Washington, DC. J Nutr 2007; 37:718S-737S.
6. Formica JV, Regelson W. Review of the biology of Quercetin nd related bioflavonoids. Food Chem Toxicol 1995;33:1061-80.
7. Cai Q, Rahn RO, Zhang R. Dietary flavonoids, quercetin, luteolin nd genistein, reduce oxidative DNA damage and lipid peroxidation nd quench free radicals. Cancer Lett 1997;119:99-107.
8. Duthie SJ, Collins AR, Duthie GG, Dobson VL. Quercetin and yricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidized pyrimidines) in human lymphocytes. Mutat Res 1997;393:223-31.
9. Noroozi M, Angerson WJ, Lean ME. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr 1998;67:1210-8.
10. Odbayar TO, Badamhand D, Kimura T, Takashi Y, Tsushida T, Ide T. Comparative studies of some phenolic compounds (quercetin, rutin, and ferulic acid) affecting hepatic fatty acid synthesis in mice. J Agric Food Chem 2006;54:8261-5.
11. Kamada C, da Silva EL, Ohnishi-Kameyama M, Moon JH, Terao J. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic Res 2005;39:185-94.
12. Igarashi K, Ohmuma M. Effects of isorhamnetin, rhamnetin, and quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities of rats. Biosci Biotechnol Biochem 1995;59: 595-601.
13. Duarte J, Pérez-Palencia R, Vargas F, Ocete MA, Pérez-Vizcaino F, Zarzuelo A, Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 2001;133:117-24.
14. Manjeet K R, Ghosh B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages. Int J Immunopharmacol 1999;21:435-43.
15. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol 2006;13:319-28.
16. Hubbard GP, Stevens JM, Cicmil M, Sage T, Jordan PA, Williams CM, Lovegrove JA, Gibbins JM. Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J Thromb Haemost 2003;1:1079-88.
17. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005;81:243S-255S.
18. Ministry of Health & Welfare. Korean food composition table. Seoul: 1996.
19. National Rural Living Science Institute. Food composition table, 5th Revision. Suwon: 1996.
20. Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich) 2009; 11:761-5.
21. Wilson PW, Meigs JB. Cardiometabolic risk: a Framingham perspective. Int J Obes (Lond) 2008;32 Suppl 2:S17-20.
22. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002;76:560-8.
23. Gnoni GV, Paglialonga G, Siculella L. Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells. Eur J Clin Invest 2009;39:761-8.
24. Glässer G, Graefe EU, Struck F, Veit M, Gebhardt R. Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites. Phytomedicine 2002;9:33-40.
25. Lee KH, Kim YH, Park EJ, Cho SR. Study on dietary habit and effect of onion powder supplementation on serum lipid levels in early diagnosed hyperlipidemic patients. J Korean Soc Food Sci Nutr 2008;37:561-70.
26. Castilla P, Echarri R, Dávalos A, Cerrato F, Ortega H, Teruel JL, Lucas MF, Gómez-Coronado D, Ortuño J, Lasunción MA. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 2006;84:252-62.
27. Zern TL, Wood RJ, Greene C, West KL, Liu Y, Aggarwal D, Shachter NS, Fernandez ML. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 2005;135: 1911-7.
28. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 2000; 130:2243-50.
29. Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008;138:1615-21.
30. Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 1998;128:593-7.
31. Egert S, Bosy-Westphal A, Seiberl J, Kürbitz C, Settler U, Plachta-Danielzik S, Wagner AE, Frank J, Schrezenmeir J, Rimbach G, Wolffram S, Müller MJ. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 2009;102:1065-74.
32. DeMarini DM. Genotoxicity of tobacco smoke and tobacco condensate: a review. Mutat Res 2004;567:447-74.
33. Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, Liu X, Zweier JL. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol 2011;300:H388-96.
34. Ministry of Health and Social Welfare. The Korea National Health & Nutrition Examination Survey Report. Seoul: 2008.
35. Tonstad S, Andrew Johnston J. Cardiovascular risks associated with smoking: A review for clinicians. Eur J Cardiovasc Prev Rehabil 2006;13:507-14.
36. Jalili T, Carlstrom J, Kim S, Freeman D, Jin H, Wu TC, Litwin SE, Symons JD. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J Cardiovasc Pharmacol 2006;47:531-41.
37. García-Saura MF, Galisteo M, Villar IC, Bermejo A, Zarzuelo A, Vargas F, Duarte J. Effects of chronic quercetin treatment in experimental renovascular hypertension. Mol Cell Biochem 2005; 270:147-55.
38. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007;137:2405-11.
39. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 2005; 51:117-23.
40. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988;5:113-24.
41. Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008;16:2081-7.